{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:12:54Z","timestamp":1764731574194},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.contraception.2014.11.011","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T20:58:31Z","timestamp":1416949111000},"page":"204-210","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill"],"prefix":"10.1016","volume":"91","author":[{"given":"Andrew M.","family":"Kaunitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Portman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn L.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Daniel R.","family":"Mishell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Foegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.contraception.2014.11.011_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2307\/2991517","article-title":"Trends in contraceptive use in the United States: 1982\u20131995","volume":"30","author":"Piccinino","year":"1998","journal-title":"Fam Plann Perspect"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.011_bb0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.contraception.2010.08.003","article-title":"Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project","volume":"83","author":"Pittman","year":"2011","journal-title":"Contraception"},{"issue":"10","key":"10.1016\/j.contraception.2014.11.011_bb0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/09513590.2010.538095","article-title":"High levels of women\u2019s satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study","volume":"27","author":"Jakimiuk","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"2 Suppl. 2","key":"10.1016\/j.contraception.2014.11.011_bb0020","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\/Evra) among North American women","volume":"77","author":"Archer","year":"2002","journal-title":"Fertil Steril"},{"issue":"18","key":"10.1016\/j.contraception.2014.11.011_bb0025","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.011_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1363\/4009408","article-title":"Factors associated with contraceptive choice and inconsistent method use, United States, 2004","volume":"40","author":"Frost","year":"2008","journal-title":"Perspect Sex Reprod Health"},{"issue":"1","key":"10.1016\/j.contraception.2014.11.011_bb0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1503\/cmaj.1041722","article-title":"Managing weighty issues on lean evidence: the challenges of bariatric medicine","volume":"172","author":"Sharma","year":"2005","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.011_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.011_bb0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2012.10.008","article-title":"Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users","volume":"87","author":"Edelman","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.011_bb0050","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"4","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2 Pt 1","key":"10.1016\/j.contraception.2014.11.011_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/AOG.0b013e3181e79440","article-title":"Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial","volume":"116","author":"Westhoff","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.11.011_bb0060","author":"National Institutes of Health"},{"issue":"2 Pt 1","key":"10.1016\/j.contraception.2014.11.011_bb0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/AOG.0000000000000095","article-title":"Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial","volume":"123","author":"Kaunitz","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1\u20132","key":"10.1016\/j.contraception.2014.11.011_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2006.12.052","article-title":"A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry","volume":"852","author":"Licea-Perez","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"10.1016\/j.contraception.2014.11.011_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/bmc.963","article-title":"Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers","volume":"22","author":"Zhao","year":"2008","journal-title":"Biomed Chromatogr"},{"issue":"7","key":"10.1016\/j.contraception.2014.11.011_bb0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/bmc.329","article-title":"Development and validation of a high-sensitivity liquid chromatography\/tandem mass spectrometry (LC\/MS\/MS) method with chemical derivatization for the determination of ethinyl estradiol in human plasma","volume":"18","author":"Shou","year":"2004","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"10.1016\/j.contraception.2014.11.011_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2009.07.003","article-title":"The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol","volume":"81","author":"Kroll","year":"2010","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.011_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive [erratum, Contraception 2004;69(2):175]","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.011_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0010-7824(99)00083-9","article-title":"Comparative safety, efficacy, and cycle control of Lunelle\u2122 monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum\u00ae 7\/7\/7 oral contraceptive (norethindrone\/ethinyl estradiol triphasic)","volume":"60","author":"Kaunitz","year":"1999","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2014.11.011_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0010-7824(97)00024-3","article-title":"A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms","volume":"55","author":"Archer","year":"1997","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2014.11.011_bb0105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.contraception.2013.04.001","article-title":"The creeping Pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?","volume":"88","author":"Trussell","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2014.11.011_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra\u00ae) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.011_bb0115","unstructured":"Nordette\u00ae-28 (levonorgestrel and ethinyl estradiol tablets, 0.15 mg\/0.03 mg). Revised June 2013. Available at http:\/\/www.drugs.com\/pro\/nordette.html. Accessed December 18, 2014"},{"key":"10.1016\/j.contraception.2014.11.011_bb0120","series-title":"Seasonique Clinical Pharmacology and Biopharmaceutical Review","article-title":"New Drug Application 21-840","year":"2006"},{"key":"10.1016\/j.contraception.2014.11.011_bb0125","series-title":"Seasonale Clinical Pharmacology and Biopharmaceutical Review","article-title":"New Drug Application 21-522","year":"2003"},{"key":"10.1016\/j.contraception.2014.11.011_bb0130","series-title":"Levlite Clinical Pharmacology and Biopharmaceutical Review","article-title":"New Drug Application 20-860","year":"1996"},{"key":"10.1016\/j.contraception.2014.11.011_bb0135","series-title":"Study ATI-CL12 and ATI-CL13","article-title":"Agile Therapeutics, Inc","year":"2012"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.011_bb0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2014.01.013","article-title":"Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel\/ethinyl estradiol combined oral contraceptive","volume":"89","author":"Portman","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.011_bb0145","unstructured":"LYBREL\u00ae (90 mcg levonorgestrel and 20 mcg ethinyl estradiol). Revised October 2010. Available at http:\/\/labeling.pfizer.com\/showlabeling.aspx?id=489. Accessed December 18, 2014."},{"issue":"5","key":"10.1016\/j.contraception.2014.11.011_bb0150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.09.019","article-title":"Predictors of noncompliance in an oral contraceptive clinical trial","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.contraception.2014.11.011_bb0155","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/PSY.0b013e3181f01be3","article-title":"Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV\/AIDS","volume":"72","author":"Kalichman","year":"2010","journal-title":"Psychosom Med"},{"key":"10.1016\/j.contraception.2014.11.011_bb0160","series-title":"Adherence to long term therapies: evidence for action","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.contraception.2014.11.011_bb0165","first-page":"1","article-title":"Obesity and socioeconomic status in adults: United States, 2005\u20132008","volume":"50","author":"Ogden","year":"2010","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.contraception.2014.11.011_bb0170","first-page":"1","article-title":"Prevalence of obesity in the United States, 2009\u20132010","volume":"82","author":"Ogden","year":"2012","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.contraception.2014.11.011_bb0175","first-page":"355","article-title":"Unintended pregnancies and use, misuse and discontinuation of oral contraceptives","volume":"40","author":"Rosenberg","year":"1995","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.011_bb0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.contraception.2012.08.042","article-title":"Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel","volume":"87","author":"Archer","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2014.11.011_bb0185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.contraception.2014.04.018","article-title":"Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol\/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles","volume":"90","author":"Westhoff","year":"2014","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2014.11.011_bb0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/13548506.2011.608432","article-title":"Ambivalence, communication and past use: understanding what influences women\u2019s intentions to use contraceptives","volume":"17","author":"Campo","year":"2012","journal-title":"Psychol Health Med"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.011_bb0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1363\/4423612","article-title":"Pregnancy ambivalence and contraceptive use among young adults in the United States","volume":"44","author":"Higgins","year":"2012","journal-title":"Perspect Sex Reprod Health"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414007835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414007835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T12:27:01Z","timestamp":1538051221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414007835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0010782414007835"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.11.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}